|
|
|
|
|
|
|
Poster: 14
Visits: 271
Title: CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL
Authors: Nadine Kutsch ,
Centre: University Hospital of Cologne
|
|
You must be registered to reply or comment.
|
|
CLLR3 A RANDOMIZED PHASE II TRIAL EVALUATING THE CHEMOTHERAPIES FC/ B COMBINED WITH GA101 FOLLOWED BY GA101 MAINTENANCE IN RELAPSED/ REFRACTORY CLL
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 14
Visits: 271
Title: CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL
Authors: Nadine Kutsch ,
Centre: University Hospital of Cologne
|
|
|
|